Unlocking Potential in Drug Portfolios Through Rx to OTC Switch


SMi's half-day masterclass will address the challenges associated with developing drug portfolios through Rx to OTC switch alongside proven methods to overcome them as highlighted by Anna Maxwell, Director, Consumer Health of Fizz Marketing Management. The event will showcase: the specifics of Rx to OTC switch, the resurgence of switch as a growth opportunity, the navigation, the process and will present an opportunity to build a value tree for a hypothetical switch.

Why you should attend the this masterclass
• Explore the resurgence of switch as a growth opportunity
• Discuss the different types of switch alongside advantages
• Discover essential insights into switch and overcome common challenges
• Understand the value tree: risk/benefit analysis
• Identify regulatory pathways in the UK and Europe
• Build strategic relationships with key industry professionals

For more information, visit: www.smi-online.co.uk/2013pom-to-p1.asp
Contact Jonathan Collins on +44 (0) 20 7827 6734 or jcollins@smi-online.co.uk

Visitors

• Pharmacy Operations
• Procurement
• Formulation Development
• Risk Management
• Regulatory Affairs
• Research and Development Projects
• Medical Affairs
• Toxicology
• Clinical Pharmacology
• Clinical Research
• Medical Advisors
• Patient Safety
• Medical Writing

Exhibitors

• Pharmacy Operations
• Procurement
• Formulation Development
• Risk Management
• Regulatory Affairs
• Research and Development Projects
• Medical Affairs
• Toxicology
• Clinical Pharmacology
• Clinical Research
• Medical Advisors
• Patient Safety
• Medical Writing

Go to event website